Vesiculopustular drug reaction with eosinophilia and systemic symptoms induced by levetiracetam.
Journal
Skin health and disease
ISSN: 2690-442X
Titre abrégé: Skin Health Dis
Pays: England
ID NLM: 9918227353706676
Informations de publication
Date de publication:
Aug 2024
Aug 2024
Historique:
received:
10
08
2023
revised:
10
02
2024
accepted:
30
03
2024
medline:
6
8
2024
pubmed:
6
8
2024
entrez:
6
8
2024
Statut:
epublish
Résumé
Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe cutaneous adverse reaction characterised by fever, lymphadenopathy, morbilliform rash, haematologic abnormalities, and multiorgan involvement. Herein, we describe a 32-year-old female presenting with a 9-day history of facial oedema, cervical and inguinal lymphadenopathy, and a pruritic rash comprised of vesicles and pustules on her face, trunk, and extremities. Her only medications were valproate, which she had been taking for several years, and levetiracetam, which was initiated 41 days prior to rash onset. On the 16th day of her rash, she was diagnosed with DRESS induced by levetiracetam (Registry of Severe Cutaneous Adverse Reactions: 5). At this point, her absolute eosinophil count was 0.9 × 10
Identifiants
pubmed: 39104635
doi: 10.1002/ski2.384
pii: SKI2384
pmc: PMC11297525
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Pagination
e384Informations de copyright
© 2024 The Authors. Skin Health and Disease published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.
Déclaration de conflit d'intérêts
Norman, Guenther, Wu, DeClerck, and Worswick report no conflicts of interest.